SNBIF
Price
$6.55
Change
+$1.90 (+40.86%)
Updated
Feb 12 closing price
Capitalization
1.07B
SONN
Price
$1.12
Change
-$0.03 (-2.61%)
Updated
Jun 27 closing price
Capitalization
3.55M
Interact to see
Advertisement

SNBIF vs SONN

Header iconSNBIF vs SONN Comparison
Open Charts SNBIF vs SONNBanner chart's image
Sanbio
Price$6.55
Change+$1.90 (+40.86%)
Volume$200
Capitalization1.07B
Sonnet BioTherapeutics Holdings
Price$1.12
Change-$0.03 (-2.61%)
Volume$31.95K
Capitalization3.55M
SNBIF vs SONN Comparison Chart in %
Loading...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNBIF vs. SONN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNBIF is a Hold and SONN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (SNBIF: $6.55 vs. SONN: $1.12)
Brand notoriety: SNBIF and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNBIF: 100% vs. SONN: 74%
Market capitalization -- SNBIF: $1.07B vs. SONN: $3.55M
SNBIF [@Biotechnology] is valued at $1.07B. SONN’s [@Biotechnology] market capitalization is $3.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNBIF’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • SNBIF’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, SNBIF is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SONN’s TA Score shows that 4 TA indicator(s) are bullish.

  • SONN’s TA Score: 4 bullish, 3 bearish.

Price Growth

SNBIF (@Biotechnology) experienced а 0.00% price change this week, while SONN (@Biotechnology) price change was -5.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.07B) has a higher market cap than SONN($3.55M). SNBIF YTD gains are higher at: 40.860 vs. SONN (-23.288). SONN has higher annual earnings (EBITDA): -13.69M vs. SNBIF (-2.99B). SONN has higher revenues than SNBIF: SONN (1M) vs SNBIF (0).
SNBIFSONNSNBIF / SONN
Capitalization1.07B3.55M30,288%
EBITDA-2.99B-13.69M21,856%
Gain YTD40.860-23.288-175%
P/E RatioN/A0.29-
Revenue01M-
Total CashN/A2.06M-
Total DebtN/A90.4K-
FUNDAMENTALS RATINGS
SNBIF vs SONN: Fundamental Ratings
SNBIF
SONN
OUTLOOK RATING
1..100
5031
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4387
P/E GROWTH RATING
1..100
6897
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SONN's Valuation (51) in the null industry is somewhat better than the same rating for SNBIF (95). This means that SONN’s stock grew somewhat faster than SNBIF’s over the last 12 months.

SONN's Profit vs Risk Rating (100) in the null industry is in the same range as SNBIF (100). This means that SONN’s stock grew similarly to SNBIF’s over the last 12 months.

SNBIF's SMR Rating (99) in the null industry is in the same range as SONN (100). This means that SNBIF’s stock grew similarly to SONN’s over the last 12 months.

SNBIF's Price Growth Rating (43) in the null industry is somewhat better than the same rating for SONN (87). This means that SNBIF’s stock grew somewhat faster than SONN’s over the last 12 months.

SNBIF's P/E Growth Rating (68) in the null industry is in the same range as SONN (97). This means that SNBIF’s stock grew similarly to SONN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNBIFSONN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
12%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
7%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNGZX18.740.17
+0.92%
Franklin Intl Growth Adv
PLBBX38.160.22
+0.57%
Plumb Balanced Investor
NTIAX14.210.04
+0.28%
Columbia Mid Cap Index A
VEVYX45.330.12
+0.27%
Victory Sycamore Established Value Y
MVGIX17.960.04
+0.22%
MFS Low Volatility Global Equity I

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with AZTR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
AZTR - SNBIF
46%
Loosely correlated
-0.69%
RENB - SNBIF
34%
Loosely correlated
-16.16%
ANTX - SNBIF
33%
Loosely correlated
N/A
SONN - SNBIF
28%
Poorly correlated
-2.61%
RZLT - SNBIF
5%
Poorly correlated
+0.93%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and SNBIF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and SNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-2.61%
SNBIF - SONN
28%
Poorly correlated
N/A
KOD - SONN
26%
Poorly correlated
-2.38%
MCRB - SONN
25%
Poorly correlated
-4.31%
XNCR - SONN
25%
Poorly correlated
-3.10%
TPST - SONN
25%
Poorly correlated
-2.68%
More